Pharma Journalist 8947 posts 0 comments

Liquidia Technologies announced that it has amended its collaboration agreement with GlaxoSmithKline (GSK) for the development and commercialization of pharmaceuticals based upon the…
Read More...

Mölnlycke and Zuellig Pharma have announced a new partnership that will focus on providing more advanced wound care products and solutions to patients and healthcare practitioners…
Read More...

SMi Group reports: After the launch of Rocklatan in the USA, Aerie Pharmaceuticals will be discussing plans for a European approval at the Ophthalmic Drugs conference this November…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for use with other medicines to treat chronic…
Read More...

SMi Reports: Interview with expert speaker from Alliance for Safe Biologic Medicines (ASBM) released for the 2019 Biosimilars conference The 10th annual Biosimilars conference will be…
Read More...

Oxford BioTherapeutics Ltd. announced that it has received a milestone payment from Boehringer Ingelheim (BI). In addition to OBT’s two clinical stage assets, MEN1309/OBT076 and…
Read More...

Akorn, Inc. announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) related to the inspection of its Somerset, New Jersey manufacturing facility in…
Read More...

Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., announced it is advancing its novel, potentially first-in-class…
Read More...

C4X Discovery Holdings plc, a pioneering drug discovery company, entered into a collaboration with PhoreMost, a UK-based biopharmaceutical company dedicated to drugging ‘undruggable’…
Read More...

Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary…
Read More...